{"transactions":[{"id":727231,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T20:28:29.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 23, 2027 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":32000,"derivative":{"exercise_price":9.08,"expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001867450-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841387/000186745026000002/ownership.xml","form_type":"4"}},{"id":743730,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-11T01:14:15.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":34169,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 10,251 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2027 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2027 annual meeting of stockholders."}],"balance_after":34169,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":34169},"source":{"system":"sec-edgar","filing":"0001193125-26-266390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526266390/ownership.xml","form_type":"4"}},{"id":743729,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unites","published_at":"2026-06-11T01:14:15.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":24116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on June 10, 2025, and fully vested on the date of the Company's 2026 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on June 10, 2025, and fully vested on the date of the Company's 2026 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":24116},"source":{"system":"sec-edgar","filing":"0001193125-26-266390","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526266390/ownership.xml","form_type":"4"}},{"id":743728,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2026-06-11T01:14:15.000Z","date":"2026-06-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7235,"price":4.39,"value":31761.65,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 11, 2025. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs."}],"balance_after":73754,"source":{"system":"sec-edgar","filing":"0001193125-26-266390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526266390/ownership.xml","form_type":"4"}},{"id":743727,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2026-06-11T01:14:15.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":24116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."}],"balance_after":80989,"source":{"system":"sec-edgar","filing":"0001193125-26-266390","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000119312526266390/ownership.xml","form_type":"4"}},{"id":1100769,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-26T12:30:06.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":5353,"price":4.67,"value":24998.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025."}],"balance_after":5353,"source":{"system":"sec-edgar","filing":"0000950170-25-090192","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841387/000095017025090192/ownership.xml","form_type":"4"}},{"id":1105850,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T12:33:55.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 17, 2026 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":4.94,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-25-087699","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841387/000095017025087699/ownership.xml","form_type":"4"}},{"id":1115581,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-11T20:29:52.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":24116,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 7,235 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2026 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2026 annual meeting of stockholders."}],"balance_after":24116,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":24116},"source":{"system":"sec-edgar","filing":"0000950170-25-084856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025084856/ownership.xml","form_type":"4"}},{"id":1115580,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-11T20:29:52.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":false,"shares":19084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on June 11, 2024, and fully vested on the date of the Company's 2025 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on June 11, 2024, and fully vested on the date of the Company's 2025 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":19084},"source":{"system":"sec-edgar","filing":"0000950170-25-084856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025084856/ownership.xml","form_type":"4"}},{"id":1115579,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2025-06-11T20:29:52.000Z","date":"2025-06-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5725,"price":6.22,"value":35609.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 13, 2024. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs."}],"balance_after":56873,"source":{"system":"sec-edgar","filing":"0000950170-25-084856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025084856/ownership.xml","form_type":"4"}},{"id":1115578,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2025-06-11T20:29:52.000Z","date":"2025-06-10","kind":"exercise","planned":false,"acquired":true,"shares":19084,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."}],"balance_after":62598,"source":{"system":"sec-edgar","filing":"0000950170-25-084856","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017025084856/ownership.xml","form_type":"4"}},{"id":1131022,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-29T21:02:32.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning May 27, 2026."}],"balance_after":437500,"derivative":{"exercise_price":1.31,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":437500},"source":{"system":"sec-edgar","filing":"0000950170-25-079104","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017025079104/ownership.xml","form_type":"4"}},{"id":1448287,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-07-26T23:05:39.000Z","date":"2024-07-24","kind":"grant","planned":false,"acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OPKO common stock upon the vesting of the award. The\nrestricted stock units vest 50% on the second anniversary of the grant date, then 25% on each of the following two years."}],"balance_after":700579,"source":{"system":"sec-edgar","filing":"0000950170-24-087030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024087030/ownership.xml","form_type":"4"}},{"id":1467908,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-27T12:39:48.000Z","date":"2024-06-26","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 26, 2025 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":5.71,"expiration_date":"2034-06-26","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0000950170-24-078173","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841387/000095017024078173/ownership.xml","form_type":"4"}},{"id":1481256,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-13T20:18:57.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":19084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 5,725 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2025 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2025 annual meeting of stockholders."}],"balance_after":19084,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":19084},"source":{"system":"sec-edgar","filing":"0000950170-24-073033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017024073033/ownership.xml","form_type":"4"}},{"id":1481255,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-13T20:18:57.000Z","date":"2024-06-11","kind":"exercise","planned":false,"acquired":false,"shares":24712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on June 13, 2023, and fully vested on the date of the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on June 13, 2023, and fully vested on the date of the Company's 2024 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":24712},"source":{"system":"sec-edgar","filing":"0000950170-24-073033","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017024073033/ownership.xml","form_type":"4"}},{"id":1481254,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2024-06-13T20:18:57.000Z","date":"2024-06-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":7414,"price":7.86,"value":58274.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 15, 2023. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs."}],"balance_after":43514,"source":{"system":"sec-edgar","filing":"0000950170-24-073033","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017024073033/ownership.xml","form_type":"4"}},{"id":1481253,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2024-06-13T20:18:57.000Z","date":"2024-06-11","kind":"exercise","planned":false,"acquired":true,"shares":24712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."}],"balance_after":50928,"source":{"system":"sec-edgar","filing":"0000950170-24-073033","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000095017024073033/ownership.xml","form_type":"4"}},{"id":1681925,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-01-10T22:56:45.000Z","date":"2024-01-08","kind":"purchase","planned":false,"acquired":true,"shares":106989,"price":0.9293,"value":99424.8777,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Shares held by the Elizabeth G. Nabel ROTH Contributory IRA. Excludes 113,200 shares purchased in 2022. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Elizabeth G. Nabel ROTH Contributory IRA. Excludes 113,200 shares purchased in 2022. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":107489,"source":{"system":"sec-edgar","filing":"0000950170-24-003699","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024003699/ownership.xml","form_type":"4"}},{"id":1681924,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-01-10T22:56:45.000Z","date":"2024-01-08","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":0.9178,"value":458.9,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the Elizabeth G. Nabel ROTH Contributory IRA. Excludes 113,200 shares purchased in 2022. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0000950170-24-003699","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024003699/ownership.xml","form_type":"4"}},{"id":1681923,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2024-01-10T22:56:45.000Z","date":"2024-01-08","kind":"purchase","planned":false,"acquired":true,"shares":108695,"price":0.925,"value":100542.875,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power.  The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be dee admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":351442,"source":{"system":"sec-edgar","filing":"0000950170-24-003699","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000095017024003699/ownership.xml","form_type":"4"}},{"id":1841773,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-29T13:00:07.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":14240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is subject to time-based vesting. The shares underlying this option shall vest and become exercisable upon the earlier of (i) June 28, 2024 or (ii) the date of the next Annual Meeting of Stockholders of the Issuer; provided, however, that all vesting shall cease if the Reporting Person resigns from the Board of Directors (the \"Board\") of the Issuer or otherwise ceases to serve as a director, unless the Board determines that the circumstances warrant continuation of vesting."}],"balance_after":14240,"derivative":{"exercise_price":1.22,"expiration_date":"2033-06-28","underlying":"Common Stock","underlying_shares":14240},"source":{"system":"sec-edgar","filing":"0001209191-23-040130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841387/000120919123040130/doc4.xml","form_type":"4"}},{"id":1854938,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-15T21:15:27.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":24712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 7,414 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2024 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2024 annual meeting of stockholders."}],"balance_after":24712,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":24712},"source":{"system":"sec-edgar","filing":"0001209191-23-037429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919123037429/doc4.xml","form_type":"4"}},{"id":1854937,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-15T21:15:27.000Z","date":"2023-06-13","kind":"exercise","planned":false,"acquired":false,"shares":14620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on June 14, 2022, and fully vested on the date of the Company's 2023 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on June 14, 2022, and fully vested on the date of the Company's 2023 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":14620},"source":{"system":"sec-edgar","filing":"0001209191-23-037429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919123037429/doc4.xml","form_type":"4"}},{"id":1854936,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2023-06-15T21:15:27.000Z","date":"2023-06-13","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4386,"price":6.07,"value":26623.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 16, 2022. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs."}],"balance_after":26216,"source":{"system":"sec-edgar","filing":"0001209191-23-037429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919123037429/doc4.xml","form_type":"4"}},{"id":1854935,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2023-06-15T21:15:27.000Z","date":"2023-06-13","kind":"exercise","planned":false,"acquired":true,"shares":14620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."}],"balance_after":30602,"source":{"system":"sec-edgar","filing":"0001209191-23-037429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919123037429/doc4.xml","form_type":"4"}},{"id":1885617,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-19T20:36:09.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning May 18, 2024."}],"balance_after":700000,"derivative":{"exercise_price":1.58,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001209191-23-031030","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123031030/doc4.xml","form_type":"4"}},{"id":1901411,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":54054,"price":1.85,"value":99999.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power.  The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":242747,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901410,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":20009,"price":1.8472,"value":36960.6248,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power.  The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":188693,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901409,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":54346,"price":1.8399,"value":99991.2054,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power.  The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":168684,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901408,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":34338,"price":1.838,"value":63113.244,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power.  The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":114338,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901407,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":54945,"price":1.82,"value":99999.9,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19912459,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901406,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":26407,"price":1.85,"value":48852.95,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19912459,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901405,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":28538,"price":1.82,"value":51939.16,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19886052,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901404,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":10928,"price":1.83,"value":19998.24,"ownership":{"direct":true},"balance_after":263079,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901403,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":19475,"price":1.829,"value":35619.775,"ownership":{"direct":true},"balance_after":252151,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901402,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":79334,"price":1.82,"value":144387.88,"ownership":{"direct":true},"balance_after":232676,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901401,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":27624,"price":1.81,"value":49999.44,"ownership":{"direct":true},"balance_after":153342,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901400,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":27777,"price":1.8,"value":49998.6,"ownership":{"direct":true},"balance_after":125718,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901399,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":3185,"price":1.793,"value":5710.705,"ownership":{"direct":true},"balance_after":97941,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":1901398,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2023-05-08T11:03:54.000Z","date":"2023-05-05","kind":"purchase","planned":false,"acquired":true,"shares":19285,"price":1.78,"value":34327.3,"ownership":{"direct":true},"balance_after":94756,"source":{"system":"sec-edgar","filing":"0001209191-23-027852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919123027852/doc4.xml","form_type":"4"}},{"id":2188929,"issuer":{"id":4969,"kind":"organization","name":"Candel Therapeutics, Inc.","symbol":"CADL"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-08-10T12:05:18.000Z","date":"2022-08-08","kind":"grant","acquired":true,"shares":28480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares underlying this option shall vest and become exercisable on August 8, 2023, with the remainder vesting in two (2) equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":28480,"derivative":{"exercise_price":3.38,"expiration_date":"2032-08-08","underlying":"Common Stock","underlying_shares":28480},"source":{"system":"sec-edgar","filing":"0000899243-22-028202","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1841387/000089924322028202/doc4.xml","form_type":"4"}},{"id":2222346,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:52:42.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":80000,"price":2.47,"value":197600.0,"ownership":{"direct":false,"nature":"Held by Nabel Family Investments LLC"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by the Nabel Family Investments LLC, of which the Reporting Person is the manager with sole investment power and has an approximately 48% interest through the parent trust, the 2009 Nabel Family Children's Trust of which the Reporting Person has sole control, and sole investment power.  The Reporting Per disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be dee admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001209191-22-039341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122039341/doc4.xml","form_type":"4"}},{"id":2222345,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:52:42.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":33777,"price":2.5,"value":84442.5,"ownership":{"direct":false,"nature":"Held by the EGN 2021 TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19857514,"source":{"system":"sec-edgar","filing":"0001209191-22-039341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122039341/doc4.xml","form_type":"4"}},{"id":2222344,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:52:42.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":15200,"price":2.4975,"value":37962.0,"ownership":{"direct":false,"nature":"Held by the EGN 2021 TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19823737,"source":{"system":"sec-edgar","filing":"0001209191-22-039341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122039341/doc4.xml","form_type":"4"}},{"id":2222343,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:52:42.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":31023,"price":2.495,"value":77402.385,"ownership":{"direct":false,"nature":"Held by the EGN 2021 TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19808537,"source":{"system":"sec-edgar","filing":"0001209191-22-039341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122039341/doc4.xml","form_type":"4"}},{"id":2222342,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:52:42.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":13229,"price":2.5,"value":33072.5,"ownership":{"direct":false,"nature":"Held by the GJN 2021 TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19857514,"source":{"system":"sec-edgar","filing":"0001209191-22-039341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122039341/doc4.xml","form_type":"4"}},{"id":2222341,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:52:42.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":65280,"price":2.4999,"value":163193.472,"ownership":{"direct":false,"nature":"Held by the GJN 2021 TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19844285,"source":{"system":"sec-edgar","filing":"0001209191-22-039341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122039341/doc4.xml","form_type":"4"}},{"id":2222340,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-24T23:52:42.000Z","date":"2022-06-22","kind":"purchase","acquired":true,"shares":1491,"price":2.495,"value":3720.045,"ownership":{"direct":false,"nature":"Held by the GJN 2021 TRUST"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19779005,"source":{"system":"sec-edgar","filing":"0001209191-22-039341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122039341/doc4.xml","form_type":"4"}},{"id":2224524,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-22T20:45:02.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":19777514,"ownership":{"direct":false,"nature":"Held by the EGN 2021 TRUST"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 amendment is being filed to report the acquisition of shares of the Issuer's common stock by the GJN 2021 TRUST and the EGN 2021 TRUST, in each case, pursuant to the ModeX Merger (as defined below), inadvertently omitted in the original Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in exchange for 2,250,000 shares of ModeX held directly by the EGN 2021 TRUST in connection with the ModeX Merger."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Shares held by the EGN 2021 TRUST for the benefit of the Reporting Person and his descendants, and for which an independent trustee has been appointed. The Reporting Person and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19777514,"source":{"system":"sec-edgar","filing":"0001209191-22-038694","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122038694/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-11"}},{"id":2224523,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-06-22T20:45:02.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":19777514,"ownership":{"direct":false,"nature":"Held by the GJN 2021 TRUST"},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This Form 4 amendment is being filed to report the acquisition of shares of the Issuer's common stock by the GJN 2021 TRUST and the EGN 2021 TRUST, in each case, pursuant to the ModeX Merger (as defined below), inadvertently omitted in the original Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received in exchange for 2,250,000 shares of ModeX Therapeutics, Inc., a Delaware corporation (\"ModeX\"), held directly by the GJN 2021 TRUST in connection with the Agreement and Plan of Merger, dated as of May 9, 2022, by and among the Issuer, ModeX, Orca Acquisition Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Issuer, and Gary J. Nabel, solely in his capacity as sellers' representative, pursuant to which ModeX became a wholly owned subsidiary of the Issuer (the \"ModeX Merger\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by the GJN 2021 TRUST for the benefit of the Reporting Person's spouse and descendants, and for which the Reporting Person's spouse serves as co-trustee together with an independent trustee. The Reporting Person's spouse and the independent trustee serve as investment advisors of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":19777514,"source":{"system":"sec-edgar","filing":"0001209191-22-038694","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122038694/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-11"}},{"id":2230535,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-16T21:47:22.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":14620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"RSUs represent contingent rights to receive common stock of the Company on a one-for-one basis, of which up to 4,386 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2023 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs fully vest on the date of the Company's 2023 annual meeting of stockholders."}],"balance_after":14620,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":14620},"source":{"system":"sec-edgar","filing":"0001209191-22-037562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919122037562/doc4.xml","form_type":"4"}},{"id":2230534,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-16T21:47:22.000Z","date":"2022-06-14","kind":"exercise","acquired":false,"shares":22831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on June 15, 2021, and fully vested on the date of the Company's 2022 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on June 15, 2021, and fully vested on the date of the Company's 2022 annual meeting of stockholders."}],"balance_after":0,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":22831},"source":{"system":"sec-edgar","filing":"0001209191-22-037562","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919122037562/doc4.xml","form_type":"4"}},{"id":2230533,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2022-06-16T21:47:22.000Z","date":"2022-06-14","kind":"disposition_to_issuer","acquired":false,"shares":6849,"price":10.26,"value":70270.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 17, 2021. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Reflects RSUs that were cash-settled, per the terms of the compensation program for Board Directors and as noted on the Form 4 filed on June 17, 2021. Partial cash-settlement of RSUs under the Board compensation program is designed to address tax obligations in connection with the vesting of RSUs."}],"balance_after":15982,"source":{"system":"sec-edgar","filing":"0001209191-22-037562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919122037562/doc4.xml","form_type":"4"}},{"id":2230532,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $.0001 per share","published_at":"2022-06-16T21:47:22.000Z","date":"2022-06-14","kind":"exercise","acquired":true,"shares":22831,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis."}],"balance_after":22831,"source":{"system":"sec-edgar","filing":"0001209191-22-037562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919122037562/doc4.xml","form_type":"4"}},{"id":2264465,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-05-19T20:28:15.000Z","date":"2022-05-18","kind":"purchase","acquired":true,"shares":68492,"price":2.9,"value":198626.8,"ownership":{"direct":true},"balance_after":75471,"source":{"system":"sec-edgar","filing":"0001209191-22-030517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122030517/doc4.xml","form_type":"4"}},{"id":2264464,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Common Stock","published_at":"2022-05-19T20:28:15.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":6979,"price":2.65,"value":18494.35,"ownership":{"direct":true},"balance_after":6979,"source":{"system":"sec-edgar","filing":"0001209191-22-030517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122030517/doc4.xml","form_type":"4"}},{"id":2275228,"issuer":{"id":4891,"kind":"organization","name":"OPKO HEALTH, INC."},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Innovation Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-12T01:44:27.000Z","date":"2022-05-09","kind":"grant","acquired":true,"shares":34923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in four equal annual installments beginning May 9, 2023."}],"balance_after":34923,"derivative":{"exercise_price":3.1989,"expiration_date":"2032-05-08","underlying":"Common Stock","underlying_shares":34923},"source":{"system":"sec-edgar","filing":"0001209191-22-028435","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/944809/000120919122028435/doc4.xml","form_type":"4"}},{"id":2664727,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-17T20:41:14.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":22831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (\"RSUs\") represent contingent rights to receive common stock of SIGA Technologies, Inc. (the \"Company\") on a one-for-one basis, of which up to 6,849 RSUs are expected to settle in cash value thereof but may be settled in shares at the discretion of the board of directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs fully vest on the date of, and immediately prior to, the Company's 2022 annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs fully vest on the date of, and immediately prior to, the Company's 2022 annual meeting of stockholders."}],"balance_after":22831,"derivative":{"underlying":"Common Stock, par value $.0001 per share","underlying_shares":22831},"source":{"system":"sec-edgar","filing":"0001209191-21-041458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919121041458/doc4.xml","form_type":"4"}},{"id":2664726,"issuer":{"id":6205,"kind":"organization","name":"SIGA TECHNOLOGIES INC"},"owners":[{"id":35576,"kind":"person","name":"Nabel Gary J.","position":1,"cik":"0001867450","reported_name":"Nabel Gary J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2021-06-17T20:41:14.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest immediately upon the grant of such options."}],"balance_after":25000,"derivative":{"exercise_price":6.57,"expiration_date":"2031-06-15","underlying":"Common Stock, par value $.0001 per share","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-041458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1010086/000120919121041458/doc4.xml","form_type":"4"}}]}